Researchers Find Genetic, Cellular Features of Early-Onset Colorectal Cancer in Chinese Patients
The findings of this new multiomics study in Chinese patients could pave the way for development of precision therapies for early-onset colorectal cancer patients.
Single-cell transcriptome sequencing and spatial omics technologies have helped pave the way for a traditionally genetics-focused crowd to pursue proteins.
Diagnostics Developer Early is Good Raises $4M in Seed Funding
The company will use the funds to complete clinical trials for its first product, BCDx, a laboratory-developed test for early bladder cancer detection.
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
NanoString Technologies, OHSU Partner on Breast Cancer Spatial Protein Profiling Assay Development
A new GeoMx Digital Spatial Profiler assay will have up to 30 protein targets and will be validated for potential use as a laboratory-developed test.